Table 2.
Variable | Control period | Intervention period | Periodb | Time | Period × time | |||||
---|---|---|---|---|---|---|---|---|---|---|
M | SD | M | SD | F c | p | F c | p | F c | p | |
SL (min) | 32.2 | 17.8 | 29.2 | 17.7 | 0.75 | 0.399 | 1.19 | 0.261 | 0.85 | 0.649 |
TST (min) | 444.3 | 89.3 | 461.2 | 95.2 | 10.08 | 0.005∗∗ | 0.99 | 0.471 | 0.98 | 0.483 |
SE (%) | 72.9 | 11.3 | 74.6 | 12.0 | 4.26 | 0.054 | 0.95 | 0.519 | 1.02 | 0.435 |
DLSSP (min) | 173.0 | 52.1 | 186.2 | 62.6 | 4.46 | 0.049∗ | 1.33 | 0.159 | 0.76 | 0.754 |
WTASO (min) | 129.6 | 59.8 | 125.8 | 70.0 | 0.31 | 0.586 | 0.59 | 0.914 | 0.75 | 0.767 |
EMA (times)a | 1.5 | 2.5 | 0.7 | 1.5 | −2.59 | 0.010∗ | ||||
NPI | 6.4 | 6.0 | 5.6 | 6.0 | 3.86 | 0.065 | 2.67 | 0.083 | 5.41 | 0.032∗ |
Note. aZ-value refers to overall time of each period effect using Wilcoxon signed rank test.
bPeriod comparing the control and intervention periods.
c F-value refers to main and alternate effects using two-way ANOVA.
N = 19.
∗ p < 0.05, ∗∗p < 0.01.